Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

NCT01697956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: BDP
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.